8,986 Shares in Nutex Health Inc. (NASDAQ:NUTX) Bought by Squarepoint Ops LLC

Squarepoint Ops LLC bought a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,986 shares of the company's stock, valued at approximately $285,000. Squarepoint Ops LLC owned approximately 0.17% of Nutex Health at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Topline Capital Management LLC acquired a new stake in Nutex Health during the fourth quarter worth about $5,690,000. Essex Investment Management Co. LLC raised its position in Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after purchasing an additional 33,024 shares during the last quarter. American Century Companies Inc. bought a new position in Nutex Health in the 4th quarter worth approximately $1,362,000. Ancora Advisors LLC bought a new position in Nutex Health in the 4th quarter worth approximately $1,334,000. Finally, Truist Financial Corp grew its holdings in Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company's stock worth $1,127,000 after acquiring an additional 6,454 shares during the period. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Trading Down 1.1%

Shares of NASDAQ:NUTX opened at $122.02 on Friday. The company's 50-day moving average price is $132.63 and its two-hundred day moving average price is $74.59. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. Nutex Health Inc. has a one year low of $4.16 and a one year high of $184.28. The stock has a market capitalization of $679.16 million, a PE ratio of -13.00 and a beta of 0.04.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping the consensus estimate of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

Wall Street Analyst Weigh In

NUTX has been the subject of several research analyst reports. Maxim Group boosted their price target on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a report on Tuesday, May 20th. Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Finally, Benchmark boosted their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th.

Insider Activity

In other news, CFO Jon Christian Bates bought 1,000 shares of the company's stock in a transaction dated Tuesday, April 8th. The shares were bought at an average cost of $81.81 per share, with a total value of $81,810.00. Following the acquisition, the chief financial officer now owns 4,888 shares in the company, valued at $399,887.28. This trade represents a 25.72% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 38.52% of the stock is owned by insiders.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.